{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:08:14Z","timestamp":1772150894526,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2025,5,20]]},"abstract":"<jats:sec id=\"jah310731-sec-0001\" xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">Non\u2013vitamin K oral anticoagulants are recommended over vitamin K antagonists in patients with nonvalvular atrial fibrillation (AF). However, the risk of gastrointestinal bleeding may be higher with non\u2013vitamin K oral anticoagulants versus vitamin K antagonists. Patients after successful transcatheter aortic valve replacement (TAVR) who are elderly and frail have worse outcomes with major gastrointestinal bleeding (MGIB), including death. This study evaluated incidence, predictors, and impact of MGIB among patients with AF after successful TAVR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec id=\"jah310731-sec-0002\" xml:lang=\"en\">\n            <jats:title>Methods<\/jats:title>\n            <jats:p xml:lang=\"en\">This on\u2010treatment analysis of ENVISAGE\u2010TAVI AF (Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation) included patients who received \u22651 dose of the study drug. Demographic, clinical, and procedural characteristics were compared between patients with versus without an MGIB event. Cox multivariable regression analysis identified predictors of MGIB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec id=\"jah310731-sec-0003\" xml:lang=\"en\">\n            <jats:title>Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Of 1377 patients in this analysis, 83 (6.0%) experienced MGIB, with 56 (67.5%) of these patients receiving edoxaban. Patients with versus without MGIB were more likely to have undergone percutaneous coronary intervention \u226430\u2009days before TAVR (9.6% versus 4.2%;\n              <jats:italic toggle=\"no\">P<\/jats:italic>\n              =0.03), a higher ejection fraction (mean\u00b1SD, 58.0\u00b110.4 versus 55.3\u00b111.5;\n              <jats:italic toggle=\"no\">P<\/jats:italic>\n              =0.04), and carotid artery disease (13.3% versus 6.6%;\n              <jats:italic toggle=\"no\">P<\/jats:italic>\n              =0.04). Edoxaban without dose adjustment versus vitamin K antagonist use (\n              <jats:italic toggle=\"no\">P<\/jats:italic>\n              =0.003), smoking (\n              <jats:italic toggle=\"no\">P<\/jats:italic>\n              =0.01), low hemoglobin levels (\n              <jats:italic toggle=\"no\">P<\/jats:italic>\n              &lt;0.0001), and percutaneous coronary intervention \u226430\u2009days before TAVR (\n              <jats:italic toggle=\"no\">P<\/jats:italic>\n              =0.01) emerged as predictors of MGIB.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec id=\"jah310731-sec-0004\" xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">In this ENVISAGE\u2010TAVI AF subanalysis, MGIB occurred in 6.0% of patients with prevalent or incident AF undergoing TAVR, and those receiving edoxaban versus vitamin K antagonists had a higher risk of MGIB. A priori identification of risk factors for MGIB may help optimize outcomes for patients with AF undergoing TAVR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec id=\"jah310731-sec-0005\" xml:lang=\"en\">\n            <jats:title>Registration<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              URL:\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\">https:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n              ; unique identifier: NCT02943785.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.123.033321","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T09:35:58Z","timestamp":1747301758000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Comparing Major Gastrointestinal Bleeding in Patients Receiving Edoxaban Versus Warfarin After Transcatheter Aortic Valve Replacement: Results From the Randomized ENVISAGE\u2010TAVI AF Trial"],"prefix":"10.1161","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7502-8049","authenticated-orcid":false,"given":"George D.","family":"Dangas","sequence":"first","affiliation":[{"name":"Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital","place":["New York, USA"]},{"name":"National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3601-8187","authenticated-orcid":false,"given":"Martin","family":"Unverdorben","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc.","place":["Basking Ridge, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3015-3361","authenticated-orcid":false,"given":"Johny","family":"Nicolas","sequence":"additional","affiliation":[{"name":"The Mount Sinai Hospital","place":["New York, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8284-2994","authenticated-orcid":false,"given":"Christian","family":"Hengstenberg","sequence":"additional","affiliation":[{"name":"Vienna General Hospital, Medical University","place":["Vienna, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1117-8085","authenticated-orcid":false,"given":"Cathy","family":"Chen","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc.","place":["Basking Ridge, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6047-0990","authenticated-orcid":false,"given":"Helge","family":"M\u00f6llmann","sequence":"additional","affiliation":[{"name":"St. Johannes\u2010Hospital","place":["Dortmund, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Jin","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc.","place":["Basking Ridge, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fayaz","family":"Shawl","sequence":"additional","affiliation":[{"name":"White Oak Medical Center","place":["Silver Spring, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5210-6382","authenticated-orcid":false,"given":"Masanori","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Toyohashi Heart Center","place":["Toyohashi, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5985-4815","authenticated-orcid":false,"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[{"name":"Shonan Kamakura General Hospital","place":["Kamakura, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Hambrecht","sequence":"additional","affiliation":[{"name":"Bremer Institute for Heart and Circulation Research at Klinikum Links der Weser","place":["Bremen, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Duggal","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc.","place":["Basking Ridge, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2732-1205","authenticated-orcid":false,"given":"Nicolas M.","family":"Van Mieghem","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Centre, Thoraxcenter","place":["Rotterdam, The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310907"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(13)62343-0"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000665"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2111016"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.01.238"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2018.07.006"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"e_1_3_2_9_2","volume-title":"Product Information","author":"Lixiana (edoxaban)","year":"2018","unstructured":"Lixiana (edoxaban) . Product Information. Daiichi Sankyo Co., Ltd; 2018."},{"key":"e_1_3_2_10_2","volume-title":"Prescriber Guide","author":"Lixiana (edoxaban)","year":"2018","unstructured":"Lixiana (edoxaban) . Prescriber Guide. Daiichi Sankyo Europe GmbH; 2018."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13065"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.116.003432"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12186025"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21885"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.271"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.15.1821"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0616-6"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvab059"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2022.200135"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.117.003998"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.123.033321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T12:05:18Z","timestamp":1747742718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.123.033321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,5,20]]}},"alternative-id":["10.1161\/JAHA.123.033321"],"URL":"https:\/\/doi.org\/10.1161\/jaha.123.033321","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"2024-02-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e033321"}}